A new study found that stimulating CB2, a receptor involved in immune cell function, improved cognitive performance in Alzheimer's disease (AD) mouse models. Researchers showed that activating CB2 ...

An F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. patent details new cannabinoid CB2 receptor modulators reported to be useful for the treatment of neuropathic pain, asthma, osteoporosis, ...

N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA ...

Past research has shown that activating CB1 and CB2 receptors with plant-derived compounds can slow down early tumor growth in various cancers, as they act as mediators, triggering different ...

InMed Pharmaceuticals Inc., a pharmaceutical company focusing on developing small molecule drug candidates for high unmet medical needs, recently announced the granting of an international Patent ...

While some have proposed that terpenes compete with THC at CB1 and CB2 receptors, essentially acting as a block against THC binding, little research seems to support this claim. While one commonly ...